Quick Answer
BIOLARGO, INC. reported Operating Income of -$14.86 million for fiscal year 2025.
BIOLARGO, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$14.86M | -243.0% |
| 2024 | -$4.33M | +5.4% |
| 2023 | -$4.58M | +15.0% |
| 2022 | -$5.39M | +20.5% |
| 2021 | -$6.78M | +10.6% |
| 2020 | -$7.58M | -13.2% |
| 2019 | -$6.70M | -4.4% |
| 2018 | -$6.41M | -8.8% |
| 2017 | -$5.90M | -19.5% |
| 2016 | -$4.93M | -18.0% |
| 2015 | -$4.18M | -23.3% |
| 2014 | -$3.39M | -29.5% |
| 2013 | -$2.62M | +44.5% |
| 2012 | -$4.72M | -49.2% |
| 2011 | -$3.16M | +24.7% |
| 2010 | -$4.20M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.18M | -576.7% | -298.4% |
| June 30, 2025 | -$1.80M | -102.5% | +3.2% |
| March 31, 2025 | -$1.86M | -144.0% | -75.5% |
| September 30, 2024 | -$1.06M | +31.0% | -19.2% |
| June 30, 2024 | -$890.0K | +42.9% | -16.6% |
| March 31, 2024 | -$763.0K | -60.0% | +50.4% |
| September 30, 2023 | -$1.54M | -63.0% | +1.4% |
| June 30, 2023 | -$1.56M | -18.0% | -226.8% |
- BIOLARGO, INC. showed a decrease of -243.0% in Operating Income compared to the prior fiscal year.
- Over the 2010–2025 period, BIOLARGO, INC.’s operating income has declined by 253.8% (from -$4.20 million to -$14.86 million).
- The most recent figure is from BIOLARGO, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: